Contract research firm Parexel is said to garner takeover interest from Private equity giant EQT and a consortium of three other buyout majors.
A consortium of Cinven, Centerbridge and GTCR is working on a bid for the contract research organization, according to traders, who cited a Bloomberg report.
Parexel is said to have received interest from about 10 parties.
Bloomberg reported in April Parexel’s PE owner Pamplona Capital Management was exploring a sale of the company in a deal that could value Parexel at about $9B including debt.
The potential sale comes after some other big deals for CROs earlier this year including Thermo Fisher’s (NYSE:TMO) planned $17B deal for PPD (NASDAQ:PPD) and Icon PLC’s agreement to purchase PRA Health (NASDAQ:PRAH) for about $12B.
Source: Seeking Alpha
Can’t stop reading? Read more
Blackstone taps bond market as private credit BDCs end issuance drought
Blackstone taps bond market as private credit BDCs end issuance drought Blackstone's private...
EQT raises the stakes with revised $12.3bn bid for Intertek
EQT raises the stakes with revised $12.3bn bid for Intertek EQT has tabled an improved takeover...
Temasek’s Azalea bets on evergreen structure to democratise private equity access
Temasek's Azalea bets on evergreen structure to democratise private equity access Azalea, a unit...